Ceribell, an AI-powered neurodiagnostics firm based in Sunnyvale, California, has announced the appointment of former Pfizer lawyer, Louisa Daniels, as its first General Counsel. Daniels brings an impressive track record to the position, boasting over three decades of experience in the biopharma industry. Her professional journey includes an extensive tenure at Pfizer where she served as Vice President and Assistant General Counsel from 2008 to 2021. Discover more about this appointment.
The addition of Daniels to Ceribell’s executive team comes at a pivotal time for the company which has recently attracted $220 million in funding to propel its innovative initiatives forward. These initiatives include a revolutionizing approach to seizure management and the enhancement of detecting neurological conditions, areas where Daniels is expected to lend her extensive legal and commercial insights.
As Ceribell continues its growth trajectory, the company is expected to benefit immensely from Daniels’ deep-rooted experience and expertise in the biopharma industry. Her appointment as the first General Counsel underlines Ceribell’s commitment to strengthening its legal governance while aligning with its ambitious vision in the field of AI-powered diagnostics.